Table of Contents Author Guidelines Submit a Manuscript
AIDS Research and Treatment
Volume 2012 (2012), Article ID 197501, 9 pages
http://dx.doi.org/10.1155/2012/197501
Research Article

Orthotopic Liver Transplantation in Human-Immunodeficiency-Virus-Positive Patients in Germany

1Department of Internal Medicine I, University of Bonn, 53105 Bonn, Germany
2Department of General, Visceral and Transplantation Medicine, University Hospital Essen, 45122 Essen, Germany
3Department of General, Visceral and Transplantation Surgery, University Hospital Essen, 45122 Essen, Germany
4Department of Internal Medicine, University of Hamburg, 20251 Hamburg, Germany
5Department of Internal Medicine, Frankfurt University, Hospital Medical Centre, 60590 Frankfurt, Germany
6Department of Internal Medicine I, University of Regensburg, 93042 Regensburg, Germany
7Department of Internal Medicine, Heidelberg University, 69125 Heidelberg, Germany
8Department of Internal Medicine, Mainz University, 55122 Mainz, Germany
9Department of Immunology and Rheumatology, Medical University of Hannover, 30625 Hannover, Germany
10Department of Internal Medicine, Tübingen University Medical School, 72076 Tübingen, Germany
11Department of Surgery, University of Bonn, 53105 Bonn, Germany

Received 11 January 2012; Accepted 9 May 2012

Academic Editor: Raffaele Bruno

Copyright © 2012 E. Anadol et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. M. Lee, J. M. Karon, R. Selik, J. J. Neal, and P. L. Fleming, “Survival after AIDS diagnosis in adolescents and adults during the treatment era, United States, 1984–1997,” Journal of the American Medical Association, vol. 285, no. 10, pp. 1308–1315, 2001. View at Google Scholar · View at Scopus
  2. A. Mocroft, B. Ledergerber, C. Katlama et al., “Decline in the AIDS and death rates in the EuroSIDA study: an observational study,” The Lancet, vol. 362, no. 9377, pp. 22–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. K. Rockstroh and U. Spengler, “HIV and hepatitis C virus co-infection,” Lancet Infectious Diseases, vol. 4, no. 7, pp. 437–444, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Konopnicki, A. Mocroft, S. De Wit et al., “Hepatitis B and HIV: prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort,” AIDS, vol. 19, no. 6, pp. 593–601, 2005. View at Google Scholar · View at Scopus
  5. I. Bica, B. McGovern, R. Dhar et al., “Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection,” Clinical Infectious Diseases, vol. 32, no. 3, pp. 492–497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Merchante, J. A. Girón-González, M. González-Serrano et al., “Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease,” AIDS, vol. 20, no. 1, pp. 49–57, 2006. View at Google Scholar · View at Scopus
  7. A. L. Mindikoglu, A. Regev, and L. S. Magder, “Impact of human immunodeficiency virus on survival after liver transplantation: analysis of united network for organ sharing database,” Transplantation, vol. 85, no. 3, pp. 359–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. M. M. Miro, L. Castells, J. Meneu et al., “5-year survival of HCV/HIV-co-infected liver transplant recipients: a case/control study,” in Proceedings of the 16th Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 2009.
  9. D. Joshi, V. Aluvihare, A. Belgaumkar et al., “UK liver transplant experience of HIV: long term outcomes,” Journal of Hepatology, vol. 50, no. 1, p. S23, 2009. View at Google Scholar
  10. E. Teicher, J.-C. Duclos Vallee, D. Samuel et al., “Liver transplantation in 88 HIV-infected patients,” in Proceedings of the 16th CROI Conference on Retroviruses and Opportunistic Infections, Montreal, Canada, 2009.
  11. Unos, “MELD/PELD calculator documentation,” http://optn.transplant.hrsa.gov/resources/professionalResources.asp?index=8.
  12. C. C. Tan-Tam, L. A. Frassetto, and P. G. Stock, “Liver and kidney transplantation in HIV-infected patients,” AIDS Reviews, vol. 11, no. 4, pp. 190–204, 2009. View at Google Scholar · View at Scopus
  13. D. Samuel, R. Weber, P. Stock, J. C. Duclos-Vallée, and N. Terrault, “Are HIV-infected patients candidates for liver transplantation?” Journal of Hepatology, vol. 48, no. 5, pp. 697–707, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. M. V. Ragni, S. H. Belle, K. Im et al., “Survival of human immunodeficiency virus-infected liver transplant recipients,” Journal of Infectious Diseases, vol. 188, no. 10, pp. 1412–1420, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Vittecoq, E. Teicher, M. Merad, J. D. Vallée, E. Dussaix, and D. Samuel, “Liver transplantation is it possible in HIV/HCV co-infected patients?” Pathologie Biologie, vol. 51, no. 8-9, pp. 525–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Norris, C. Taylor, P. Muiesan et al., “Outcomes of liver transplantation in HIV-infected individuals: the impact of HCV and HBV infection,” Liver Transplantation, vol. 10, no. 10, pp. 1271–1278, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Moreno, C. Cervera, J. Fortn et al., “Epidemiology and outcome of infectins in HIV/HCV-coinfected liver transplant recipients: a FIPSE/GESIDA prospective cohort study,” Liver Transplantation and Surgery, vol. 18, no. 1, pp. 70–81, 2012. View at Publisher · View at Google Scholar
  18. J. C. Duclos-Vallée, C. Féray, M. Sebagh et al., “Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus,” Hepatology, vol. 47, no. 2, pp. 407–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. M. E. de Vera, I. Dvorchik, K. Tom et al., “Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C,” American Journal of Transplantation, vol. 6, no. 12, pp. 2983–2993, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. L. Castells, J. I. Esteban, I. Bilbao et al., “Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients,” Antiviral Therapy, vol. 11, no. 8, pp. 1061–1070, 2006. View at Google Scholar · View at Scopus
  21. T. M. Antonini, M. Sebagh, A. M. Roque-Afonso et al., “Fibrosing cholestatic hepatitis in HIV/HCV co-infected transplant patients-usefulness of early markers after liver transplantation,” American Journal of Transplantation, vol. 11, no. 8, pp. 1686–1695, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Wojcik, M. Vogel, E. Voigt et al., “Antiviral therapy for hepatitis C virus recurrence after liver transplantation in HIV-infected patients: outcome in the Bonn cohort,” AIDS, vol. 21, no. 10, pp. 1363–1365, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Beckebaum, V. R. Cicinnati, and X. Zhang, “Combination therapy with peginterferon alpha-2B and ribavirin in liver transplant recipients with recurrent HCV infection: preliminary results of an open prospective study,” Transplantation Proceedings, vol. 36, no. 5, pp. 1489–1491, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. J. K. Rockstroh, S. Bhagani, Y. Benhamou et al., “European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults,” HIV Medicine, vol. 9, no. 2, pp. 82–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Vogel, E. Voigt, N. Schäfer et al., “Orthotopic liver transplantation in human immunodeficiency virus (HIV)-positive patients: outcome of 7 patients from the bonn cohort,” Liver Transplantation, vol. 11, no. 12, pp. 1515–1521, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Berenguer, J. Álvarez-Pellicer, P. M. Martín et al., “Sustained virological response to interferon plus ribavirin reduces liver-related complications and mortality in patients coinfected with human immunodeficiency virus and hepatitis C virus,” Hepatology, vol. 50, no. 2, pp. 407–413, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. N. A. Terrault, J. T. Carter, L. Carlson, M. E. Roland, and P. G. Stock, “Outcome of patients with hepatitis B virus and human immunodeficiency virus infections referred for liver transplantation,” Liver Transplantation, vol. 12, no. 5, pp. 801–807, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. Joshi, V. Aluvihare, A. Belgaumkar et al., “Liver transplantation for HIV: analysis of outcomes suggest HIV/HCV co-infected patients have prohibitively poor survival at 5 years,” Hepatology, vol. 48, supplement 1, p. 311, 2008. View at Google Scholar
  29. P. G. Stock and M. E. Roland, “Evolving clinical strategies for transplantation in the HIV-positive recipient,” Transplantation, vol. 84, no. 5, pp. 563–571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. C. S. Coffin, P. G. Stock, L. M. Dove et al., “Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients,” American Journal of Transplantation, vol. 10, no. 5, pp. 1268–1275, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. N. Qurishi, C. Kreuzberg, G. Lüchters et al., “Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection,” The Lancet, vol. 362, no. 9397, pp. 1708–1713, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Vogel, E. Voigt, H. C. Michaelis et al., “Management of drug-to-drug interactions between cyclosporine A and the protease-inhibitor lopinavir/ritonavir in liver-transplanted HIV-infected patients,” Liver Transplantation, vol. 10, no. 7, pp. 939–944, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Tricot, E. Teicher, G. Peytavin et al., “Safety and efficacy of raltegravir in hiv-infected transplant patients cotreated with immunosuppressive drugs,” American Journal of Transplantation, vol. 9, no. 8, pp. 1946–1952, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Mauss, “Treatment of viral hepatitis in HIV-coinfected patients-adverse events and their management,” Journal of Hepatology, vol. 44, supplement 1, pp. S114–S118, 2006. View at Publisher · View at Google Scholar · View at Scopus